CD8A and cancer: Despite the suppressive effects of obesity, immunotherapy regimens using anti–PD-1 alone or in combination with an experimental cancer vaccine led to tumor rejection in lean and obese mice and partially restored a proinflammatory CD8 T cell phenotype.